Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Mesa Laboratories (MLAB) over the last 11 years, with Q4 2023 value amounting to $5.4 million.

  • Mesa Laboratories' Shares Outstanding (Weighted Average) rose 101.14% to $5.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.4 million, marking a year-over-year increase of 101.14%. This contributed to the annual value of $3.5 million for FY2015, which is 220.61% up from last year.
  • According to the latest figures from Q4 2023, Mesa Laboratories' Shares Outstanding (Weighted Average) is $5.4 million, which was up 101.14% from $5.4 million recorded in Q3 2023.
  • Mesa Laboratories' Shares Outstanding (Weighted Average)'s 5-year high stood at $5.4 million during Q4 2023, with a 5-year trough of $5.2 million in Q3 2021.
  • Over the past 3 years, Mesa Laboratories' median Shares Outstanding (Weighted Average) value was $5.3 million (recorded in 2022), while the average stood at $5.3 million.
  • As far as peak fluctuations go, Mesa Laboratories' Shares Outstanding (Weighted Average) soared by 214.93% in 2022, and later surged by 101.14% in 2023.
  • Mesa Laboratories' Shares Outstanding (Weighted Average) (Quarter) stood at $5.2 million in 2021, then grew by 2.03% to $5.3 million in 2022, then rose by 1.01% to $5.4 million in 2023.
  • Its Shares Outstanding (Weighted Average) stands at $5.4 million for Q4 2023, versus $5.4 million for Q3 2023 and $5.3 million for Q4 2022.